|
|
|
|
|
|
|
|
Version 2.2015
This Article
-
J Natl Compr Canc Netw 2016;14:153-162
The NCCN Guidelines for Genetic/Familial
High-Risk Assessment: Breast and Ovarian provide recommendations for
genetic testing
and counseling and risk assessment and management
for hereditary cancer syndromes. Guidelines focus on syndromes
associated
with an increased risk of breast and/or ovarian
cancer and are intended to assist with clinical and shared
decision-making.
These NCCN Guidelines Insights summarize major
discussion points of the 2015 NCCN Genetic/Familial High-Risk
Assessment: Breast
and Ovarian panel meeting. Major discussion topics
this year included multigene testing, risk management recommendations
for
less common genetic mutations, and salpingectomy
for ovarian cancer risk reduction. The panel also discussed revisions to
genetic testing criteria that take into account
ovarian cancer histology and personal history of pancreatic cancer.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.